)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
Crescent Biopharma
Crescent Biopharma (CBIO) investor relations material
Crescent Biopharma Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary21 Apr, 2026
Voting matters and shareholder proposals
Election of two Class II directors, Jonathan Violin, Ph.D., and Susan Moran, M.D., MSCE, for terms expiring at the 2029 Annual General Meeting or until a successor is elected or earlier departure.
Additional business may be addressed if properly brought before the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of the nominated Class II directors.
Shareholder rights and capital structure
Shareholders are invited to vote virtually at the annual meeting scheduled for June 2, 2026, or online prior to the meeting.
Proxy materials and annual report are available online, with options for paper or email copies upon request.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Crescent Biopharma
- Virtual meeting to elect directors, ratify auditor, and approve executive pay and governance.CBIO
Proxy filing21 Apr 2026 - Key votes include director election, auditor ratification, and annual say-on-pay approval.CBIOProxy filing21 Apr 2026
- Advancing PD-1/VEGF bispecific and ADCs with global trials and key data expected in 2027.CBIOLeerink Global Healthcare Conference 202611 Mar 2026
- Multiple oncology studies launching, with pivotal data and strong financial runway into 2028.CBIOTD Cowen 46th Annual Health Care Conference2 Mar 2026
- Expanded oncology pipeline and strong cash position support multiple clinical milestones into 2028.CBIOQ4 202526 Feb 2026
- Global trials for CR-001 and ADCs advance, with key data and partnerships expected by 2027.CBIOGuggenheim Securities Emerging Outlook: Biotech Summit 202612 Feb 2026
- Dual strategy targets IO and ADCs, with CR-001 clinical data expected by late 2026.CBIOStifel 2025 Healthcare Conference29 Dec 2025
- Transformational partnership and $185M financing accelerate global IO and ADC trials for 2026-2027.CBIOPartnership6 Dec 2025
- CR001 and ADCs drive a global, well-funded oncology strategy with key data expected by late 2026.CBIOJefferies London Healthcare Conference 202519 Nov 2025
Next Crescent Biopharma earnings date
Q1 202614 May, 2026
Crescent Biopharma
Next Crescent Biopharma earnings date
Q1 202614 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
)
Business philosophy22 Apr 2026
Benedetto Vigna: The CEO of Ferrari
An unexpected leader for Ferrari: how semiconductor expert Benedetto Vigna became CEO and why his background fits the industry's shift.
Frequently asked questions
Explore our global coverage